Medical card holders will be required to pay out of pocket for a new pharmacy prescription service set to launch by the end of 2025, as the government has allocated no state funding to cover the costs for Ireland’s most vulnerable patients.
The service, designed to allow pharmacists to prescribe treatments for eight common conditions including thrush, cold sores, and urinary tract infections, was originally scheduled to begin at the start of this year but has faced significant delays.
Service Aims to Reduce GP Pressure
The initiative is being developed primarily to ease pressure on general practitioners by enabling pharmacists to treat routine conditions without requiring patients to visit their doctor first. However, critics argue that excluding medical card holders undermines the service’s effectiveness.
Pharmacists will be authorized to prescribe for allergic rhinitis, cold sores, conjunctivitis, impetigo, oral thrush, shingles, uncomplicated UTIs, and vulvovaginal thrush once the necessary protocols and training are completed.
Department Defends Funding Decision
A Department of Health spokesperson defended the decision not to provide state funding, describing it as part of “sustainable reform” that will empower pharmacists to “seize opportunities” and diversify their “business models.”
The spokesperson noted that medical card holders currently receive free GP consultations and pay only the statutory prescription charge for medications, suggesting the new service represents an additional option rather than a replacement for existing care pathways.
“The common conditions service will increase capacity across primary care,” the department added, emphasizing the broader healthcare system benefits.
Opposition Criticizes Access Barriers
Sinn Féin health spokesperson David Cullinane sharply criticized the funding arrangement, arguing that it effectively blocks medical card holders from accessing the service and limits its potential to reduce GP workloads.
“Of course medical card holders should be able to get the consultations with pharmacists through their medical card, it’s ridiculous to think that they wouldn’t,” Cullinane told The Journal.
He highlighted the project’s troubled timeline, noting that former Health Minister Stephen Donnelly had promised the service would be operational by early 2025, despite planning beginning in 2023.
Implementation Challenges Continue
The Expert Taskforce supporting pharmacy role expansion was established in October 2023 and delivered its recommendations nearly a year later. However, the implementation process has proven more complex than initially anticipated.
An Implementation Oversight Group comprising representatives from the Department of Health, Health Service Executive, Irish Pharmacies Union, and Health Products Regulatory Authority is currently developing the necessary protocols, legislation, and training requirements.
Tom Murray, President of the Irish Pharmacies Union, previously warned against imposing new responsibilities on an “underfunded and resourced group of healthcare professionals” without adequate support.
Broader Healthcare Access Concerns
The controversy highlights ongoing tensions in Irish healthcare policy between expanding service access and controlling costs. Medical card holders, who typically include the elderly, unemployed, and low-income families, may find themselves unable to benefit from a service explicitly designed to improve healthcare accessibility.
The delayed implementation and funding gap raise questions about the government’s commitment to equitable healthcare reform, particularly as pressure on GP services continues to intensify across the country.